Health in Honduras 1,067 indicators covering health for Honduras. IndicatorLatest Year10-yr change Rank Share of public expenditure on healthcare by country 31.92 2023 down 22.5% 154th Private health expenditure per person 321 2023 up 71.0% 107th Public healthcare spending share gdp 2.46 2023 down 29.6% 113th Health spending per person by source 176.69 2023 up 22.2% 136th Poliomyelitis - number of reported cases 0 2018 — 8th Number of new hiv infections per year 436.07 2024 down 4.9% 95th Rubella vaccination coverage 79 2024 down 18.6% 147th Deaths from aids un 339.76 2024 down 58.9% 73rd Mortality rate among children ages 10 to 14 years 3.08 2020 up 7.6% 49th Cost healthy diet 4.75 2024 up 28.7% 58th Terrorism deaths by region 0 2021 down 100.0% 58th Medical doctors 20,251 2023 up 725.2% 74th Adults (ages 15-49) newly infected with HIV 500 2024 unchanged 87th People with basic handwashing facilities including soap and water 85.0% 2024 up 0.8% 46th Number of new hiv child infections vs number of infections averted due 39.71 2024 down 27.6% 64th Mean systolic blood pressure 120.9 2015 up 0.3% 131st UHC Service Coverage sub-index on infectious diseases 87 2023 up 13.0% 115th UHC Service Coverage sub-index on service capacity and access 33 2023 unchanged 172nd UHC Service Coverage sub-index on reproductive, maternal, newborn and 76 2023 up 2.7% 73rd UHC Service Coverage Index 64 2023 up 4.9% 132nd UHC Service Coverage sub-index on noncommunicable diseases 76 2023 up 2.7% 9th Stillbirth rate 8 2023 down 18.5% 102nd Number of stillbirths 1,886 2023 down 13.7% 79th Hepb3 number unvaccinated 61,795 2023 up 2,763.9% 50th Rotavirus vaccines completed dose (RotaC) immunization coverage among 87.0% 2025 down 12.1% 46th Young people (ages 15-24) newly infected with HIV 100 2024 unchanged 83rd Tb related deaths hiv 49 2023 down 39.5% 87th Smoking bans in public places 8 2022 unchanged 1st Current health expenditure (CHE) as percentage of gross domestic produ 7.7% 2023 down 9.1% 67th External health expenditure (EXT) as percentage of current health expe 10.1% 2023 up 91.4% 62nd Domestic general government health expenditure (GGHE-D) as percentage 31.9% 2023 down 22.5% 155th Out-of-pocket expenditure as percentage of current health expenditure 53.1% 2023 up 7.7% 28th Domestic general government health expenditure (GGHE-D) as percentage 2.5% 2023 down 29.6% 114th Domestic general government health expenditure (GGHE-D) as percentage 9.4% 2023 down 20.2% 107th Domestic private health expenditure (PVT-D) as percentage of current h 58.0% 2023 up 8.4% 32nd Current health expenditure (CHE) per capita in US$ 249.15 2023 up 41.2% 123rd Domestic private health expenditure (PVT-D) per capita in US$ 144.5 2023 up 53.0% 98th Domestic general government health expenditure (GGHE-D) per capita in 79.54 2023 up 9.4% 132nd Total healthcare expenditure gdp 7.71 2023 down 9.1% 67th Health expenditure government expenditure 9.43 2023 down 20.2% 108th Mumps - number of reported cases 211 2025 up 95.4% 41st Incidence of tuberculosis (per 100 000 population) 1.9 2023 down 55.8% 87th Hib vaccine 75 2024 down 24.2% 152nd Congenital Rubella Syndrome - number of reported cases 0 2025 — 16th External health expenditure (EXT) per capita in US$ 25.11 2023 up 170.4% 29th People with basic handwashing facilities including soap and water, rur 84.3% 2024 up 3.8% 35th Nursing and midwifery personnel 7,825 2023 up 27.3% 135th Nursing personnel 7,810 2023 up 27.1% 127th People using safely managed drinking water services, rural 45.5% 2024 up 7.2% 41st Raised blood pressure (SBP>=140 OR DBP>=90) 22.85 2019 down 13.7% 160th Raised blood pressure (SBP>=140 OR DBP>=90) 20.56 2019 down 11.2% 179th Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 65.8% 2019 up 15.4% 39th Hypertension among adults aged 30-79 years, prevalence, age-standardiz 33.9 2019 up 0.6% 130th Hypertension effective treatment coverage (controlled hypertension )am 32.6% 2019 up 52.3% 26th Hypertension: effective treatment coverage (controlled hypertension) a 31.9% 2019 up 51.2% 30th Hypertension treatment coverage among adults aged 30-79 with hypertens 55.8% 2019 up 19.5% 41st Hypertension treatment coverage among adults aged 30-79 with hypertens 58.3% 2019 up 18.5% 25th Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 63.6% 2019 up 16.3% 62nd Hypertension among adults aged 30-79 years, prevalence, crude 30.2 2019 up 3.1% 160th Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati 86.0% 2025 down 13.1% 92nd ← Previous Page 10 of 18 Next →